Dual‑chamber pacemakers for symptomatic bradycardia due to sick sinus syndrome and/or atrioventricular block

  • Technology appraisal guidance
  • TA88
  • Published: 
  • Last updated: 

TA88 Bradycardia - dual chamber pacemakers: review decision

Following consultation, the majority of comments received have led to the decision to defer the review of the original guidance until the completion of the DANPACE trial currently anticipated in December 2009.

At this point the evidence base will again be assessed to ascertain the need for a review of the guidance.

 

10 July 2007

This page was last updated: 24 December 2010